Found 389 matching trials
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 PHASE1 The purpose of this study is to find the number of natural killer (NK) cell...
Show More Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients N/A The purpose of this study is to collect data from patients by social media ...
Show More Location
Lymphoma House086
Learn More & Join Trial
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia PHASE1 This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers PHASE1 This is an open-label, multi-center study to evaluate the safety, tolerabil...
Show More Location
USC/Norris Comprehensive Cancer Center
Learn More & Join Trial
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation PHASE1 The investigators propose a nonrandomized, Phase I study to assess the safe...
Show More Location
Hammersmith Hospital
Learn More & Join Trial
Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer PHASE1 The aim of this study is the safety and efficacy of cryosurgery plus NK imm...
Show More Location
Cancer Institute in Fuda cancer hospital
Learn More & Join Trial
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer PHASE1 This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors PHASE1 This is a Phase 1 open-label, study designed to characterize the safety, to...
Show More Location
Washington University School of Medicine
Learn More & Join Trial